“…Soft tissue sarcomas account for <1.5% of all malignant neoplasms in adults. 14 An array of soft tissue sarcomas with Sarcomatoid mesothelioma Larger and less uniform nuclei, 2 single cells and loose aggregates, short spindle-shaped cells without microvilli 30 Calretinin, podoplanin (D2-40), WT1, CK5/6, mesothelin 31 Synovial sarcoma Mixed population of cohesive tissue fragments and scattered cells, tissue fragments contain thin branching capillaries, mitosis and mast cells present, sometimes admixed with epithelial-like structures 20,21 Epithelial membrane antigen, CK7, 24 CK19, 24 BCL2 (nearly 100% of synovial sarcoma cases), CD56 (nearly 100% of synovial sarcoma cases), 25 CD99 (60% of synovial sarcoma cases), 20 S100P (30% of synovial sarcoma cases), 20 TLE1(most sensitive and specific) 29 Cytogenetic analysis for detection of t(X;18)(p11.2;q11.2) translocation for confirmation of synovial sarcoma 24,28,32 musculoskeletal histology can occur in the abdomen and pelvis, posing challenging problems because of their complex anatomy and initial presentation as large masses with extensive invasion. Synovial sarcoma represents 5% to 10% of all soft tissue sarcomas.…”